Claes Held
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Internal Medicine top 0.1%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 42
- Cardiac Health and Mental Health 38
- Atrial Fibrillation Management and Outcomes 37
- Acute Myocardial Infarction Research 28
- Blood Pressure and Hypertension Studies 11
- Surgery 34
- Lipoproteins and Cardiovascular Health 15
- Coronary Interventions and Diagnostics 12
- Co-authors
- Lars C. Wallentin (97 shared papers)Stefan Karl James (39 shared papers)Christopher Paul Cannon (25 shared papers)Kenneth Mahaffey (42 shared papers)Robert A. Harrington (41 shared papers)Philippe Gabríel Steg (27 shared papers)Robert F. Storey (21 shared papers)Richard C. Becker (15 shared papers)
- Journals
- European Heart Journal (36 papers)American Heart Journal (25 papers)Circulation (23 papers)Journal of the American College of Cardiology (20 papers)Journal of the American Heart Association (13 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Claes Held
307 papers receiving 28.7k citations
Claes Held's Hit Papers
Peers
Comparison fields: 5 of 174
- Cardiology and Cardiovascular Medicine 16.4k
- Internal Medicine 2.2k
- Endocrinology, Diabetes and Metabolism 4.5k
- Surgery 6.5k
- Nephrology 815
Countries citing papers authored by Claes Held
This map shows the geographic impact of Claes Held's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claes Held with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claes Held more than expected).
Fields of papers citing papers by Claes Held
This network shows the impact of papers produced by Claes Held. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claes Held. The network helps show where Claes Held may publish in the future.
Co-authors
The 25 scholars most cited alongside Claes Held, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 324 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes Hit paper breakdown → | 2009 | 5519 |
| 2 | Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Hit paper breakdown → | 2019 | 5176 |
| 3 | Initial Invasive or Conservative Strategy for Stable Coronary Disease Hit paper breakdown → | 2020 | 1673 |
| 4 | Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease Hit paper breakdown → | 2016 | 683 |
| 5 | Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes Hit paper breakdown → | 2011 | 628 |
| 6 | 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Hit paper breakdown → | 2022 | 617 |
| 7 | Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease Hit paper breakdown → | 2016 | 470 |
| 8 | 2010 | 424 | |
| 9 | The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study Hit paper breakdown → | 2016 | 400 |
| 10 | Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study Hit paper breakdown → | 2021 | 376 |
| 11 | 2009 | 356 | |
| 12 | 2013 | 351 | |
| 13 | 2011 | 348 | |
| 14 | The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation Hit paper breakdown → | 2016 | 342 |
| 15 | Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014 Hit paper breakdown → | 2017 | 340 |
| 16 | 2011 | 301 | |
| 17 | Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease Hit paper breakdown → | 2016 | 297 |
| 18 | 2014 | 293 | |
| 19 | 2014 | 284 | |
| 20 | 2016 | 274 |
About Claes Held
Claes Held is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine, Cognitive Neuroscience and Radiology, Nuclear Medicine and Imaging, having authored 324 papers that have together received 30.0k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (42 papers), Cardiac Health and Mental Health (38 papers), Atrial Fibrillation Management and Outcomes (37 papers), Acute Myocardial Infarction Research (28 papers), Lipoproteins and Cardiovascular Health (15 papers), Coronary Interventions and Diagnostics (12 papers), Blood Pressure and Hypertension Studies (11 papers) and EEG and Brain-Computer Interfaces (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (16.4k citations), Internal Medicine (2.2k citations), Endocrinology, Diabetes and Metabolism (4.5k citations), Surgery (6.5k citations) and Nephrology (815 citations). Claes Held has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Lars C. Wallentin, Stefan Karl James, Christopher Paul Cannon, Kenneth Mahaffey, Robert A. Harrington, Philippe Gabríel Steg, Robert F. Storey, Richard C. Becker, Steen Husted and Jay Charles Horrow. Their work appears in journals such as European Heart Journal, American Heart Journal, Circulation, Journal of the American College of Cardiology and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.